IART Earnings
Latest Revenue418.8M
Latest Net Income4.5M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.06 | 418.8M | 4.5M | +0.8% | +101.0% |
| Q1 2026 | -$0.06 | 391.9M | -4617000 | +2.4% | +81.8% |
| Q4 2025 | -$0.02 | 434.9M | -1704000 | -1.7% | -108.0% |
| Q3 2025 | -$0.07 | 402.1M | -5404000 | +5.6% | +50.0% |
| Q2 2025 | -$6.31 | 415.6M | -484073000 | -0.6% | -3,843.7% |
| Q1 2025 | -$0.33 | 382.7M | -25293000 | +3.7% | -725.0% |
| Q4 2024 | $0.25 | 442.6M | 19.4M | +11.5% | +0.0% |
| Q3 2024 | -$0.14 | 380.8M | -10695000 | -0.4% | -158.3% |
| Q2 2024 | -$0.16 | 418.2M | -12402000 | — | — |
| Q1 2024 | -$0.04 | 368.9M | -3281000 | — | — |
| Q4 2023 | $0.25 | 397.0M | 19.8M | — | — |
| Q3 2023 | $0.24 | 382.4M | 19.5M | — | — |
Integra LifeSciences (IART) — Earnings